Efficacy And Safety Of Bradykinin B2 Receptor Antagonism With Oral Deucrictibant In Prophylaxis Of Hereditary Angioedema Attacks: Results Of CHAPTER-1 Phase 2 Trial

Bibliographic Details
Title: Efficacy And Safety Of Bradykinin B2 Receptor Antagonism With Oral Deucrictibant In Prophylaxis Of Hereditary Angioedema Attacks: Results Of CHAPTER-1 Phase 2 Trial
Authors: Riedl, Marc, Anderson, John, Arcoleo, Francesco, Cancian, Mauro, Chapdelaine, Hugo, Conlon, Niall, Eren, Efrem, Gompels, Mark, Grigoriadou, Sofia, Guarino, Maria, Gurugama, Padmalal, Kinaciyan, Tamar, Magerl, Markus, Manning, Michael, Stobiecki, Marcin, Tarzi, Michael, Valerieva, Anna, Wedner, H. James, Yang, William, Zanichelli, Andrea, Crabbe, Rafael, Mulders, Susan, Royston, Minying, Zhu, Li, Knolle, Jochen, Lesage, Anne, Lu, Peng, Aygören-Pürsün, Emel
Source: In The Journal of Allergy and Clinical Immunology February 2024 153(2) Supplement:AB11-AB11
Database: ScienceDirect
More Details
ISSN:00916749
DOI:10.1016/j.jaci.2023.11.057
Published in:The Journal of Allergy and Clinical Immunology
Language:English